Search clinical trials for: Conventional amphotericin B

Total 11609 results

PETHEMA Foundation

Completed

Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis (AMBINEB)

Acute Myeloid Leukemia | Allogeneic Haematopoietic Progenitor Cell Transplant

Spain
Banaras Hindu University
Rajendra Memorial Research Institute of Medical Sciences

Unknown

Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis

Visceral Leishmaniasis

India
Astellas Pharma Global Development, Inc.

Terminated

Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis (MAGIC-2)

Candidiasis

Philippines, United States, Canada, Israel, Romania, Greece, Turkey, Brazil, Bulgaria, Colombia, Hungary, Ukraine
Bharat Serums and Vaccines Limited
Ministry of Science and Technology

Completed

To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar

Leishmaniasis, Visceral

India
Aurobindo Pharma Ltd
Axis Clinicals Limited

Completed

Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition

Visceral Leishmaniasis

Bangladesh, India
Fovea
Gilead Sciences

Unknown

Ambisome® Preemptive Treatment of Multiple Candida Colonization in Sepsis Patients (AMBIDEX)

Sepsis | Candida

France
Banaras Hindu University

Completed

Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis

Visceral Leishmaniasis

India
Southeast University, China

Completed

The PK/PD of Deoxycholic Acid Amphotericin B in Invasive Fungal Infection Patients With Sepsis/Septic Shock

Fungal Infection

China
Liposome

Completed

Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome

HIV Infections | Meningitis, Cryptococcal

United States
Peking Union Medical College Hospital

Recruiting

To Evaluate the Efficacy and Safety of ABCD in the Treatment of IFD

Invasive Fungal Disease

China
Taiwan Liposome Company

Completed

An Bioequivalence Study to Compare Two 2 mg/ml Liposomal Amphotericin B Injections in Healthy Subjects

Normal Healthy Subjects
European Organisation for Research and Treatment...

Completed

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

Cancer

Belgium, Netherlands, Italy, Hungary, France, Spain, Germany, Israel, Czech Republic, United Arab Emirates, Sweden, Greece, Turkey, Portugal, Slovakia
Federal University of Health Science of Porto Alegre

Not yet recruiting

Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS (L-AmB_phase3)

Fungal Infection | Immunosuppression | AIDS and Infections | Disseminated Histoplasma Capsulatum Infection

Brazil
Matinas BioPharma Nanotechnologies, Inc.

Completed

CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis (CAMB)

Candidiasis, Chronic Mucocutaneous

United States
Matinas BioPharma Nanotechnologies, Inc.
University of Minnesota

Withdrawn

Efficacy and Safety of Oral Encochleated Amphotericin B for the Treatment of Cryptococcal Infection (ORACLE)

Cryptococcal Infections
Hospital Universitário Professor Edgard Santos

Completed

Liposomal Amphotericin in Disseminated Leishmaniasis

Disseminated Leishmaniasis

Brazil
Drugs for Neglected Diseases

Completed

Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia (Anfoleish)

Cutaneous Leishmaniasis

Colombia
Drugs for Neglected Diseases
Addis Ababa University

Terminated

Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL

Visceral Leishmaniasis

Ethiopia, Sudan
Matinas BioPharma Nanotechnologies, Inc.
University of Minnesota

Completed

Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT) (EnACT)

Cryptococcal Meningitis

Uganda
Matinas BioPharma Nanotechnologies, Inc.
University of Cologne; The Clinical Trials Centre Cologne

Withdrawn

Safety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous and Lymphoblastic Leukaemia

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Not yet recruiting

A Study of Amphotericin B Liposome for Injection in Patients With Persistent Neutropenia and Fever

Neutropenia and Fever
TTY Biopharm

Completed

A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent Fever

Neutropenia, Febrile

Taiwan
Fundació Sant Joan de Déu
Ministry of Health, Spain

Completed

Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia

Lymphoblastic Leukemia | Invasive Pulmonary Aspergillosis | Lymphoblastic Leukaemia | Myeloblastic Leukaemia | Myeloblastic Leukemia

Spain
Banaras Hindu University
Drugs for Neglected Diseases; Rajendra Memorial Research Institute of Medical...

Completed

Combination Therapy in Indian Visceral Leishmaniasis

Leishmaniasis, Visceral

India
Soroka University Medical Center

Completed

Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis

Leishmaniasis

Israel
Assistance Publique - Hôpitaux de Paris

Completed

Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment (AMBIZYGO)

Zygomycosis

France
Erasmus Medical Center
Gilead Sciences; Nexstar Pharmaceuticals

Completed

Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis

Aspergillosis

Netherlands
Banaras Hindu University

Completed

A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar

Visceral Leishmaniasis

India
Gilead Sciences

Terminated

Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics

Febrile Neutropenia

Greece
Banaras Hindu University

Completed

Amphotericin B Treatment in Visceral Leishmaniasis

Visceral Leishmaniasis

India
TTY Biopharm

Unknown

Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis

Cryptococcal Meningitis

Taiwan
Matinas BioPharma Nanotechnologies, Inc.

Withdrawn

Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis

Vulvovaginitis | Candidiasis, Vulvovaginal | Vulvovaginal Candidiases | Yeast Infection | Yeast Infection Vaginal

United States
Fundacion para la Investigacion Biomedica del Hospital...

Completed

Nebulised Liposomal Amphotericin for Invasive Pulmonary Aspergillosis (NAIFI01 Study) (NAIFI01)

Invasive Pulmonary Aspergillosis

Spain
Poitiers University Hospital

Completed

Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded). (NEBULAMB)

Allergic Bronchopulmonary Aspergillosis

France
Bill McGhee
Astellas Pharma Inc

Completed

Antifungal Locks to Treat Fungal-related Central Line Infections

Central Line Fungal Infections

United States
Drugs for Neglected Diseases
International Centre for Diarrhoeal Disease Research, Bangladesh; Shaheed Surhawardy...

Completed

Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh

Visceral Leishmaniasis

Bangladesh
University of Brasilia
Ministry of Health, Brazil

Completed

Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children (LVTO)

Visceral Leishmaniasis

Brazil
Merck Sharp & Dohme LLC

Completed

MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)

Aspergillosis
Astellas Pharma Inc

Terminated

Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for Aspergillosis

Aspergillosis

United States
Drugs for Neglected Diseases
London School of Hygiene and Tropical Medicine; Institute of Tropical Medicine... and other collaborators

Completed

Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.

Visceral Leishmaniasis

Ethiopia
Astellas Pharma Inc

Completed

Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia

Candidiasis

United States, Canada
Gilead Sciences

Terminated

ProphyALL - Study on the Safety of Liposomal Amphotericin B to Prevent Antifungal Infections in Elderly Patients With Acute Lymphoblastic Leukemia

Fungal Infection

Germany
Merck Sharp & Dohme LLC

Terminated

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)

Candidiasis, Invasive
Drugs for Neglected Diseases
Gilead Sciences; Paladin Labs Inc.

Completed

Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa

Primary Visceral Leishmaniasis

Kenya, Sudan
University of Brasilia
Ministry of Health, Brazil; Conselho Nacional de Desenvolvimento Científico... and other collaborators

Terminated

Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil (LVBrasil)

Visceral Leishmaniasis

Brazil
F2G Biotech GmbH
Iqvia Pty Ltd; Shionogi

Recruiting

Olorofim Aspergillus Infection Study (OASIS)

Invasive Aspergillosis

United States, Taiwan, Belgium, Spain, Italy, Turkey, New Zealand, China, Canada, Netherlands, Australia, Brazil, Singapore, Israel, France, Thailand, Germany, Japan, Korea, Republic of, United Kingdom
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co....

Completed

Bioequivalence of Amphotericin B Liposome for Injection

Bioequivalence

China
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co....

Completed

A Pilot Bioequivalence Study Between Amphotericin B Liposome for Injection and AmBisome® in Healthy Subjects

Bioequivalence

China
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb

Completed

A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole

HIV Infections | Candidiasis, Oral

United States, Tanzania, Puerto Rico
Capital Medical University

Unknown

Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal Transplantation

Invasive Pulmonary Aspergillosis

China

Search clinical trials for: Conventional amphotericin B

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations